Recruitment

Recruitment Status
Completed
Estimated Enrollment
600

Summary

Conditions
  • Acute Intermittent Porphyria (AIP)
  • Hereditary Coproporphyria (HCP)
  • Variegate Porphyria (VP)
Type
Observational
Design
Observational Model: CohortTime Perspective: Prospective

Participation Requirements

Age
Between 15 years and 125 years
Gender
Both males and females

Description

The porphyrias are a group of genetic diseases caused by disturbances in the formation of heme, an essential component of hemoglobin and other proteins, leading to either acute (neurologic) and/or chronic (cutaneous) symptoms. Acute porphyria is often difficult to diagnose because symptoms may not b...

The porphyrias are a group of genetic diseases caused by disturbances in the formation of heme, an essential component of hemoglobin and other proteins, leading to either acute (neurologic) and/or chronic (cutaneous) symptoms. Acute porphyria is often difficult to diagnose because symptoms may not be specific and, unless the patient is in an active attack, laboratory values typically may not be useful for diagnosing porphyria. The purpose of this study is to test whether a focused questionnaire and laboratory evaluation tool can better define risk factors associated with possible genetic porphyria. The goals of this study are: To determine the presence and number of abnormal lab tests and porphyria-like symptoms in adult family members of the first person in a family who has been diagnosed with a disease of acute porphyria, 50% of whom are expected to carry the same genetic defect of the index case. To devise a Genetic Carrie Profile that could be used to screen people in whom the diagnosis of porphyria is being considered. To test the Profile in patients with symptoms suggestive of HCP and/or urine tests showing some elevation of porphyrins. To explain other possible causes of minor increases in porphyrin levels in patients with recurrent abdominal pain who have not been diagnosed with porphyria

Tracking Information

NCT #
NCT01568554
Collaborators
  • University of Texas
  • University of Alabama at Birmingham
  • Icahn School of Medicine at Mount Sinai
  • University of Utah
  • Carolinas Medical Center
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • Rare Diseases Clinical Research Network
Investigators
Study Chair: D. Montgomery Bissell, M.D. University of California at San Francisco Principal Investigator: Karl E. Anderson, M.D. University of Texas Principal Investigator: Joseph R. Bloomer, M.D. University of Alabama at Birmingham Principal Investigator: Robert J. Desnick, Ph.D., M.D. Icahn School of Medicine at Mount Sinai Principal Investigator: James P. Kushner, M.D. University of Utah Principal Investigator: Herbert L. Bonkovsky, M.D. Carolinas Medical Center and HealthCare System